Overactive Bladder [clinicaltrials_resource:0b2e660c09e1306ab4f03a1f98040044]
clinicaltrials:NCT00131573Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome [clinicaltrials:NCT00138723]clinicaltrials:NCT00168454Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder [clinicaltrials:NCT00171184]clinicaltrials:NCT00174798A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder [clinicaltrials:NCT00189800]Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan [clinicaltrials:NCT00212706]Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan [clinicaltrials:NCT00212732]NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder [clinicaltrials:NCT00213577]Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase [clinicaltrials:NCT00220389]Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder [clinicaltrials:NCT00224146]Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder. [clinicaltrials:NCT00231491]Programmable Timer in the Bladder Rehabilitation Treatment of OAB [clinicaltrials:NCT00238680]Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach. [clinicaltrials:NCT00262496]Surface Nerve Stimulation Treatment for OAB in Children [clinicaltrials:NCT00282490]A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase II Study of MK0594 in Patients With Overactive Bladder [clinicaltrials:NCT00290563]clinicaltrials:NCT00311376Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome [clinicaltrials:NCT00313924]A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder [clinicaltrials:NCT00321477]Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients [clinicaltrials:NCT00332319]A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON) [clinicaltrials:NCT00337090]clinicaltrials:NCT00337558Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms [clinicaltrials:NCT00343486]clinicaltrials:NCT00350636clinicaltrials:NCT00425100A Two-Part Study to Determine: Best Medication Formulation and Food Effect [clinicaltrials:NCT00427596]clinicaltrials:NCT00427648clinicaltrials:NCT00431041Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity [clinicaltrials:NCT00437528]clinicaltrials:NCT00439140ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB) [clinicaltrials:NCT00439192]Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity [clinicaltrials:NCT00441428]clinicaltrials:NCT00444925clinicaltrials:NCT00448175clinicaltrials:NCT00461292clinicaltrials:NCT00465894clinicaltrials:NCT00478881This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo. [clinicaltrials:NCT00479596]Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate. [clinicaltrials:NCT00481728]Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder Syndrome and Detrusor Overactivity [clinicaltrials:NCT00495053]
condition [clinicaltrials_vocabulary:condition]
Overactive Bladder [clinicaltrials_resource:0b2e660c09e1306ab4f03a1f98040044]
Bio2RDF identifier
0b2e660c09e1306ab4f03a1f98040044
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0b2e660c09e1306ab4f03a1f98040044
identifier
clinicaltrials_resource:0b2e660c09e1306ab4f03a1f98040044
title
Overactive Bladder
@en
label
Overactive Bladder [clinicaltrials_resource:0b2e660c09e1306ab4f03a1f98040044]
@en